Pfizer's smoking cessation program under fire
Controversy over patient support programs has been reignited with criticism of arrangements between Pfizer Australia and the Pharmacy Guild of Australia to pay pharmacists for signing up consumers to smoking cessation programs.
11 weeks ago0
Champix associated with gastrointestinal effects
Use of the popular smoking cessation drug varenicline (Champix) at a maintenance dose for longer than six weeks is associated with adverse gastrointestinal effects, new research shows.
17 weeks ago0
Pfizer defends Champix safety profile
The Therapeutic Goods Administration will review the safety of the popular anti-smoking drug Champix, after research showed it increased the...
Browse our newsletter archive
Advertisement
